CN103041015B - Medicine for treatment of hepatitis - Google Patents
Medicine for treatment of hepatitis Download PDFInfo
- Publication number
- CN103041015B CN103041015B CN201210586848.8A CN201210586848A CN103041015B CN 103041015 B CN103041015 B CN 103041015B CN 201210586848 A CN201210586848 A CN 201210586848A CN 103041015 B CN103041015 B CN 103041015B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- treatment
- radix
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to medicine for treatment of hepatitis. The medicine is prepared by the raw materials in part by weight: 1-6 parts of celastrus orbiculatus, 1-6 parts of radix paeoniae alba, 1-3 parts of radix zanthoxyli and 1-3 parts of liquorice root. The medicine has obvious alleviating and therapeutic effects on hepatitis B, icterohepatitis and cirrhosis, and has the advantages of low price, non-toxic side effects and safety and reliability.
Description
Technical field
The present invention relates to a kind of medicine, specifically a kind of medicine for the treatment of hepatitis.
Background technology
Hepatitis is the inflammation of liver, and the healthy of the people in serious harm.At present, the treatment of doctor trained in Western medicine medicine adopts the medicines such as interferon, though there is certain effect, because cost is higher, uses and has certain restriction, and medicine exists obvious toxic and side effects in addition; And the traditional medicine of China treats advantage to hepatitis B and be cheap, toxic and side effects is little.
Summary of the invention
The object of the present invention is to provide one cheap, have no side effect, the medicine of safe and reliable treatment hepatitis, this medicine is made up of the raw material of following proportioning: Celastrus orbiculatus Thunb. 2-6 part, Radix Paeoniae Alba 2-6 part, Radix Zanthoxyli 1-3 part, Radix Glycyrrhizae 1-3 part.Above-mentioned medical material is ground into powder, and each serving using 10g, three times on the one, be a course for the treatment of January.
Compared with prior art, the present invention is a kind of medicine of making by new component and proportioning.Medical material is various places Common Chinese Herbs materials, with low cost.This medicine is improved the effect of liver function and liver plasma membrane.Have and be easy to make, convenient drug administration, feature evident in efficacy, especially has obvious alleviation and therapeutical effect for hepatitis B, icterohepatitis and liver cirrhosis.Nanning to numerous hepatopaths' tracking therapeutic process in, cure rate reaches more than 87%, and healing time is short, can cure a general course for the treatment of, two three courses for the treatment of at most, and do not need to take other drug during administration.Listing part model case is below proved:
Wang Jiang, man, 25 years old, anorexia, weak, complexion yellowish-brown simple and unadorned, color of the lip is dark violet, County Hospital laboratory test report shows suffers from chronic hepatitis, after treatment first quarter moon, above-mentioned symptom fades away, after the course for the treatment of, cure, chemical examination again, laboratory test report shows that liver function recovery is normal.
Zhang Caifu, man, 48 years old, suffering from liver cirrhosis, xerosis cutis is coarse, and complexion is gloomy, and has vomiting and diarrhoea, even be unable to leave the bed, after continued treatment first quarter moon, spirit takes a turn for the better, and after the course for the treatment of, the state of an illness is obviously suppressed, and can do some daily housework, after two courses for the treatment of, recover as ordinary person, after three courses for the treatment of, cure.
Wang Mingying, female, 36 years old, suffer from hepatitis A, there are the symptoms such as fear of cold, heating, stomachache, diarrhoea, dyspepsia, loss of appetite, nauseating, tired, hepatomegaly and abnormal liver function, cure after taking a course for the treatment of of this medicine.
Wang Yafeng, man, 23 years old, suffer from hepatitis B, check result is great three positive, and cardinal symptom shows as immune system disorder, and continued treatment is cured after two courses for the treatment of and is occurred protection antibody.
Wang Limou, man, 17 years old, suffer from hepatitis B, check result is small three positive, and cardinal symptom shows as immune system disorder, retarded growth, and continued treatment is cured after two courses for the treatment of and is occurred protection antibody.
Song Pingjie, man, 35 years old, suffer from acute icterohepatitisshock, the mobility of thrombinogen is lower than 40%, and serum bilirubin and alaninyl transferring enzyme are high, with after half course for the treatment of of above-mentioned treatment by Chinese herbs, mobility, serum bilirubin and the alaninyl transferring enzyme of thrombinogen all recover normal value, no longer recurrence after healing.
Wang Tao, man, 48 years old, suffering from liver cirrhosis, was unable to leave the bed, and cured two courses for the treatment of with above-mentioned Chinese medicine continued treatment, and liver function recovery is normal.
Make widely known, man, 53 years old, suffer from chronic hepatitis, cure the disease and do not heal for many years, Relapse rate, and time have an outbreak, thoroughly cure after taking two courses for the treatment of with above-mentioned Chinese medicine, after no longer recurrence.
Due to the restriction of length, the present invention does not exemplify one by one to numerous healing patients' situation separately, only using above-mentioned example as explanation.
Detailed description of the invention
The specific embodiment of the invention is as shown in the table:
Claims (6)
1. treat a medicine for hepatitis, it is characterized in that being made by following raw material components and weight proportion: Celastrus orbiculatus Thunb. 1-6 part, Radix Paeoniae Alba 1-6 part, Radix Zanthoxyli 1-3 part, Radix Glycyrrhizae 1-3 part; Above-mentioned medical material is ground into powder, each serving using 10g.
2. the medicine for the treatment of hepatitis according to claim 1, is characterized in that the weight proportion of described raw material is: 2 parts of Celastrus orbiculatus Thunb.s, 2 parts of the Radix Paeoniae Albas, 1 part of Radix Zanthoxyli, 1 part, Radix Glycyrrhizae.
3. the medicine for the treatment of hepatitis according to claim 1, is characterized in that the weight proportion of described raw material is: 6 parts of Celastrus orbiculatus Thunb.s, 4 parts of the Radix Paeoniae Albas, 2 parts of Radix Zanthoxylis, 1 part, Radix Glycyrrhizae.
4. the medicine for the treatment of hepatitis according to claim 1, is characterized in that the weight proportion of described raw material is: 4 parts of Celastrus orbiculatus Thunb.s, 6 parts of the Radix Paeoniae Albas, 1 part of Radix Zanthoxyli, 3 parts, Radix Glycyrrhizae.
5. the medicine for the treatment of hepatitis according to claim 1, is characterized in that the weight proportion of described raw material is: 6 parts of Celastrus orbiculatus Thunb.s, 6 parts of the Radix Paeoniae Albas, 2 parts of Radix Zanthoxylis, 1 part, Radix Glycyrrhizae.
6. the medicine for the treatment of hepatitis according to claim 1, is characterized in that the weight proportion of described raw material is: 6 parts of Celastrus orbiculatus Thunb.s, 2 parts of the Radix Paeoniae Albas, 3 parts of Radix Zanthoxylis, 1 part, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210586848.8A CN103041015B (en) | 2012-12-29 | 2012-12-29 | Medicine for treatment of hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210586848.8A CN103041015B (en) | 2012-12-29 | 2012-12-29 | Medicine for treatment of hepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103041015A CN103041015A (en) | 2013-04-17 |
| CN103041015B true CN103041015B (en) | 2014-09-10 |
Family
ID=48054026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210586848.8A Expired - Fee Related CN103041015B (en) | 2012-12-29 | 2012-12-29 | Medicine for treatment of hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103041015B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107970304A (en) * | 2016-10-25 | 2018-05-01 | 南宁多灵生物科技有限公司 | A kind of Chinese medicine composition for treating hepatitis |
| CN108721572B (en) * | 2018-08-21 | 2021-05-07 | 黄增琼 | A Chinese medicinal composition for treating hepatocarcinoma and liver cirrhosis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100191901B1 (en) * | 1996-04-01 | 1999-06-15 | 박원훈 | Novel sesquiterpene ester compound |
| US6524627B1 (en) * | 2002-03-20 | 2003-02-25 | Daehan Biolink Co., Ltd. | Pharmaceutical composition for preventing and treating allergic diseases and a method for preparation thereof |
| CN1319531C (en) * | 2005-06-08 | 2007-06-06 | 复旦大学 | Application of quinolines alkaloid in preparation of hepatitis B virus resisting medicine |
| CN102040642A (en) * | 2010-09-27 | 2011-05-04 | 南京泽朗医药科技有限公司 | Process for extracting pristimerin |
| CN102068510A (en) * | 2011-01-14 | 2011-05-25 | 武汉康乐药业股份有限公司 | Pharmaceutical composition for treating liver diseases and preparation method thereof |
-
2012
- 2012-12-29 CN CN201210586848.8A patent/CN103041015B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103041015A (en) | 2013-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041015B (en) | Medicine for treatment of hepatitis | |
| CN101757203B (en) | Medicament for treating hepatitis | |
| CN102973674A (en) | Eczema eliminating capsule | |
| CN103330928B (en) | Traditional Chinese medicine composition used for treating gastric ulcer and preparation method thereof | |
| CN103071140B (en) | Traditional Chinese medicinal composition for treating eczema | |
| CN102526256B (en) | Medicine for treating hepatitis | |
| CN102743658B (en) | Traditional Chinese medicinal composition for treating urticaria | |
| CN102266451A (en) | Medicament for treating infantile eczema and preparation method thereof | |
| CN103285234A (en) | Traditional Chinese medicine cuttlebone and bletilla rhizome powder for treatment of peptic ulcer | |
| CN103550665B (en) | A kind of Chinese medicine composition for the treatment of gastropathy | |
| CN107715085A (en) | A kind of Chinese medicine composition for treating chronic colitis | |
| CN106620524A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN101167917A (en) | Traditional Chinese medicine for treating aural vertigo | |
| CN106620318B (en) | Traditional Chinese medicine composition for treating chronic nephritis | |
| CN105343797A (en) | Traditional Chinese medicine composition for curing stomach illness and preparation method thereof | |
| CN105641328A (en) | Chinese patent medicine thirst quenching and blood sugar lowering Chinese medicine pill for treating diabetes | |
| CN105395733A (en) | Traditional Chinese medicine composition used for treating chronic gastritis and preparation method therefor | |
| CN104721575A (en) | Chinese medicinal composition for treatment of gastric bleeding | |
| CN102743574B (en) | Compound Chinese herbal medicine capsule for treating and killing mycobacterium tuberculosis and preparation method | |
| CN104096194A (en) | Traditional Chinese medicine for treating vomiting caused by deficiency-cold in spleen and stomach | |
| CN104161918A (en) | Traditional Chinese medicine for treating allergic pneumonia | |
| CN108114028A (en) | A kind of drug for treating canker sore | |
| CN105920181A (en) | Traditional Chinese medicinal composition for treating cutaneous pruritus and preparation method of traditional Chinese medicinal composition | |
| CN104645267A (en) | Xiaoqinglong essence | |
| CN105412853A (en) | Traditional Chinese medicine formula for treating chilblains |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140910 Termination date: 20171229 |